Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price rises 2.23% today
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Share Price rose to Rs 2,809.25 today, up 2.23% from the previous close of Rs 2,747.85, while the company’s market capitalisation stood at Rs 20,886.87 Cr. The move places Caplin Point Laboratories Ltd. in today’s stock news flow as a notable share price rise in the healthcare space. Based on the supplied data, the article confirms the price event and the day’s trading range, but it does not establish a company-specific catalyst. For readers tracking Caplin Point Laboratories Share Price Today, the useful context is the size of the move, the turnover of Rs 0.17 Cr, and how the stock compares with sector valuation and peer metrics. Univest will continue to track the stock through its market data and analysis framework.
Caplin Point Laboratories Share Price also matters because the company is already valued at a premium to the wider industry medians on some metrics, while still sitting inside a sector that includes much larger listed names. That combination makes Caplin Point Laboratories Stock News relevant for investors who watch price action alongside fundamentals, sector positioning and ownership structure.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,809.25 |
| Previous Close | Rs 2,747.85 |
| Today's Move | Rs 61.4 (+2.23%) |
| Open | Rs 2,760 |
| High | Rs 2,815.95 |
| Low | Rs 2,710 |
| Turnover | Rs 0.17 crore |
| Market Capitalisation | Rs 20,886.87 crore |
| Market Cap Category | Large Cap |
Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,809.25 from the previous close of Rs 2,747.85, a move of Rs 61.4 or 2.23%. The stock opened at Rs 2,760, reached a high of Rs 2,815.95, recorded a low of Rs 2,710.
Caplin Point Laboratories Share Price today opened at Rs 2,760, touched a high of Rs 2,815.95 and a low of Rs 2,710, before settling at Rs 2,809.25. The stock gained Rs 61.40 over the previous close of Rs 2,747.85, and the supplied data confirms a same-day price rise. The turnover for the session was Rs 0.17 Cr. No company-specific catalyst is confirmed in the supplied data, so the event should be read as a verified price move rather than a reason-based story. For Caplin Point Laboratories Share Price Today searches, these figures capture the day’s movement, range and closing level.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,886.87 crore |
| P/E Ratio | 31.39x |
| P/B Ratio | 5.69x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.29% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 31.39x, P/B 5.69x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 20886.87 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.39x, P/B at 5.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.29%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.39x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 5.69x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 20,886.87 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.39x, which is below the benchmark median of 32.87x, a difference of -4.5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.7%, a difference of +77.69%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.46%, a difference of +85.51%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.39x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 20,886.87 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price rose 2.23% today to Rs 2,809.25.
- The stock moved Rs 61.40 above the previous close of Rs 2,747.85.
- Market capitalisation stands at Rs 20,886.87 Cr for Caplin Point Laboratories Share Price.
- P/E is 31.39, P/B is 5.69, EPS is Rs 87.53 and book value is Rs 483.17.
- ROE of 20.79% and ROCE of 24.97% compare favourably with the industry medians.
About Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not break out product segments or revenue mix, so the company is best understood here through its listed financial and market profile. Caplin Point Laboratories Share Price is being tracked because the company combines a sizeable market capitalisation with strong return ratios and a valuation that can be compared against a broad same-industry benchmark. Its earnings per share of Rs 87.53 and book value of Rs 483.17 provide a useful snapshot of underlying financial scale, while the dividend yield of 0.29% shows a modest payout profile. For readers following Caplin Point Laboratories Stock News, the main company-level takeaway is that the business sits inside a competitive pharmaceutical universe where valuation, profitability and relative market size all matter.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Caplin Point Laboratories Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Caplin Point Laboratories Share Price Today alongside company news, sector context and peer comparison in one place. For Caplin Point Laboratories Stock Analysis, that combination makes it easier to review the numbers that matter without separating the stock story from the wider market backdrop.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Caplin Point Laboratories Share Price rising today?
Ans. The supplied data confirms a same-day price rise of 2.23% to Rs 2,809.25. It does not establish a company-specific catalyst, so the event should be read as a verified market move.
What is Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price today is Rs 2,809.25. It moved up Rs 61.40 from the previous close of Rs 2,747.85, with the day’s high at Rs 2,815.95. The previous close was Rs 2,747.85.
What is Caplin Point Laboratories market capitalisation?
Ans. Caplin Point Laboratories has a market capitalisation of Rs 20,886.87 Cr. That places the company above the industry median in the supplied benchmark set, while still below the largest healthcare peers.
How does Caplin Point Laboratories compare on valuation?
Ans. The stock trades at a P/E of 31.39 and a P/B of 5.69. Its P/E is below the industry median, while its P/B is above the median and average in the benchmark universe.
What do Caplin Point Laboratories ROE and ROCE show?
Ans. Caplin Point Laboratories reports ROE of 20.79% and ROCE of 24.97%. Both are above the industry median and average in the supplied same-industry benchmark, which adds profitability context. ROE stands at 20.79%.
What are the EPS and book value for Caplin Point Laboratories?
Ans. EPS is Rs 87.53 and book value is Rs 483.17. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share.
Does Caplin Point Laboratories pay a dividend?
Ans. The supplied dividend yield is 0.29%. That is historical payout data linked to the current price, so it provides context for income-oriented analysis rather than a guarantee of future payouts.
